Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,810 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial.
Bryan RT, Liu W, Pirrie SJ, Amir R, Gallagher J, Hughes AI, Jefferson KP, Knight A, Nanton V, Mintz HP, Pope AM, Cherian J, Ekwueme K, Gommersall L, Hellawell G, Hunter-Campbell P, Kanda Swamy G, Kotwal S, Kumar V, Mak D, Mohee A, Nambirajan T, Ward DG, Kennish SJ, Catto JWF, Patel P, James ND; BladderPath Collaborative Group. Bryan RT, et al. Among authors: gallagher j. J Clin Oncol. 2025 Jan 14:JCO2302398. doi: 10.1200/JCO.23.02398. Online ahead of print. J Clin Oncol. 2025. PMID: 39808757
Discovery of non-retinoid compounds that suppress the pathogenic effects of misfolded rhodopsin in a mouse model of retinitis pigmentosa.
Ortega JT, Gallagher JM, McKee AG, Tang Y, Carmena-Bargueňo M, Azam M, Pashandi Z, Golczak M, Meiler J, Pérez-Sánchez H, Schlebach JP, Jastrzebska B. Ortega JT, et al. Among authors: gallagher jm. PLoS Biol. 2025 Jan 14;23(1):e3002932. doi: 10.1371/journal.pbio.3002932. eCollection 2025 Jan. PLoS Biol. 2025. PMID: 39808594 Free PMC article.
Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study.
Shields RK, Abbo LM, Ackley R, Aitken SL, Albrecht B, Babiker A, Burgoon R, Cifuentes R, Claeys KC, Curry BN, DeSear KE, Gallagher JC, Golnabi EY, Gross AE, Hand J, Heil EL, Hornback KM, Kaye KS, Khuu TV, Klatt ME, Kline EG, Kubat RC, Kufel WD, Lee JH, Lepak AJ, Lim A, Ludwig JM, Macdougall C, Majumdar A, Mathers AJ, McCreary EK, Miller WR, Monogue ML, Moore WJ, Olson S, Oxer J, Pearson JC, Pham C, Pinargote P, Polk C, Satlin MJ, Satola SW, Shah S, Tamma PD, Tran TT, van Duin D, VanNatta M, Vega A, Venugopalan V, Veve MP, Wangchinda W, Witt LS, Wu JY, Pogue JM; PRECEDENT Network. Shields RK, et al. Among authors: gallagher jc. Lancet Infect Dis. 2024 Dec 16:S1473-3099(24)00648-0. doi: 10.1016/S1473-3099(24)00648-0. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39701120
2,810 results